Mon, February 3, 2025
Sun, February 2, 2025
Sat, February 1, 2025
Fri, January 31, 2025
Thu, January 30, 2025
[ Thu, Jan 30th ] - Politico
RFK Jr.'s health tech fix
Wed, January 29, 2025
Tue, January 28, 2025
Mon, January 27, 2025
Sun, January 26, 2025
[ Sun, Jan 26th ] - Newsday
Technology news
Sat, January 25, 2025
Fri, January 24, 2025
Thu, January 23, 2025

India raising the bar on drug formulation challenges


//science-technology.news-articles.net/content/2 .. sing-the-bar-on-drug-formulation-challenges.html
Published in Science and Technology on by MSN   Print publication without navigation

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.

The article from MSN discusses India's significant strides in the pharmaceutical sector, particularly in drug formulation. It highlights how India has become a global hub for generic drugs, with companies like Sun Pharma, Dr. Reddy's Laboratories, and Cipla leading the charge. The piece outlines the challenges faced by the Indian pharmaceutical industry, including stringent regulatory compliance, intellectual property rights issues, and the need for innovation in drug delivery systems. Despite these challenges, India is pushing forward with investments in research and development, aiming to not only produce cost-effective generics but also to develop new formulations and improve drug delivery technologies. The article also touches on the government's role in fostering an environment conducive to pharmaceutical growth through policy support and incentives for R&D. This reflects India's ambition to elevate its status from a generic drug manufacturer to a leader in pharmaceutical innovation.

Read the Full MSN Article at:
[ https://www.msn.com/en-in/science/biochemistry/india-raising-the-bar-on-drug-formulation-challenges/ar-AA1xZ927 ]

Publication Contributing Sources